Paper17823293
Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW and 7 others. Am J Pathol, 2007. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Papers, record 17823293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17823293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Apyrase | Major topic |
| Integrins | Major topic |
| Neovascularization, Pathologic | Major topic |
| Purines | Major topic |
| Animals | |
| Cell Adhesion | |
| Cell Proliferation | |
| Endothelium, Vascular | |
| Gene Deletion | |
| Integrin alphaVbeta3 | |
| Melanoma, Experimental | |
| Mice | |
| Mice, Mutant Strains | |
| Neoplasm Transplantation | |
| Protein Kinases | |
| Receptors, Purinergic P2 | |
| Signal Transduction |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI45897 | NIAID NIH HHS | United States | P01AI045897 | PubMed and NIH | NIH RePORTER |
| P01 AI045897 | NIAID NIH HHS | United States | P01AI045897 | PubMed and NIH | NIH RePORTER |
| HL076540 | NHLBI NIH HHS | United States | P01HL076540 | PubMed and NIH | NIH RePORTER |
| R01 HL063972 | NHLBI NIH HHS | United States | R01HL063972 | PubMed and NIH | NIH RePORTER |
| HL63972 | NHLBI NIH HHS | United States | R01HL063972 | PubMed and NIH | NIH RePORTER |
| P01 HL076540 | NHLBI NIH HHS | United States | P01HL076540 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10742145 | Mechanisms of angiogenesis and arteriogenesis. | Nat Med | 2000 | https://conductscience.org/library/papers/10742145 | PubMed |
| 2 | 12386143 | Regulation of G protein-coupled receptor signaling by scaffold proteins. | Circ Res | 2002 | https://conductscience.org/library/papers/12386143 | PubMed |
| 3 | 10766752 | Distinct antitumor properties of a type IV collagen domain derived from basement membrane. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10766752 | PubMed |
| 4 | 10955784 | Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10955784 | PubMed |
| 5 | 11001068 | Angiogenesis in cancer and other diseases. | Nature | 2000 | https://conductscience.org/library/papers/11001068 | PubMed |
| 6 | 11007955 | Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. | Biochem Pharmacol | 2000 | https://conductscience.org/library/papers/11007955 | PubMed |
| 7 | 11071621 | Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. | Blood | 2000 | https://conductscience.org/library/papers/11071621 | PubMed |
| 8 | 11331301 | An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. | J Cell Biol | 2001 | https://conductscience.org/library/papers/11331301 | PubMed |
| 9 | 11748109 | Disordered cellular migration and angiogenesis in cd39-null mice. | Circulation | 2001 | https://conductscience.org/library/papers/11748109 | PubMed |
| 10 | 11786895 | Integrin indecision. | Nat Med | 2002 | https://conductscience.org/library/papers/11786895 | PubMed |
| 11 | 12640026 | Focal adhesion kinase: the first ten years. | J Cell Sci | 2003 | https://conductscience.org/library/papers/12640026 | PubMed |
| 12 | 13680353 | Integrins in angiogenesis: multitalented molecules in a balancing act. | Cell Tissue Res | 2003 | https://conductscience.org/library/papers/13680353 | PubMed |
| 13 | 14722085 | RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14722085 | PubMed |
| 14 | 15161625 | Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15161625 | PubMed |
| 15 | 7507113 | A mechanism for divalent cation regulation of beta 3-integrins. | J Biol Chem | 1994 | https://conductscience.org/library/papers/7507113 | PubMed |
| 16 | 7938164 | Nomenclature and classification of purinoceptors. | Pharmacol Rev | 1994 | https://conductscience.org/library/papers/7938164 | PubMed |
| 17 | 8756718 | Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. | Cell | 1996 | https://conductscience.org/library/papers/8756718 | PubMed |
| 18 | 8955160 | Identification and characterization of CD39/vascular ATP diphosphohydrolase. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8955160 | PubMed |
| 19 | 9916135 | Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. | J Clin Invest | 1999 | https://conductscience.org/library/papers/9916135 | PubMed |
| 20 | 10470077 | Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. | Nat Med | 1999 | https://conductscience.org/library/papers/10470077 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42137061 | Integrating multi-omics, machine learning, and molecular dynamics simulations to identify glutamate metabolism-related biomarkers and drug candidates in rheumatoid arthritis. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42137061 | PubMed |
| 41575692 | The purinergic signaling interfaces in breast cancer angiogenesis. | Purinergic Signal | 2026 | https://conductscience.org/library/papers/41575692 | PubMed |
| 40534663 | Insights from Clinical Trials on A2A Adenosine Receptor Antagonists for Cancer Treatment. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40534663 | PubMed |
| 40303330 | ATP released by ultrasound targeted microbubble cavitation induces vascular inflammation and improves immune checkpoint blockade efficacy. | Theranostics | 2025 | https://conductscience.org/library/papers/40303330 | PubMed |
| 39329710 | Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects. | Cells | 2024 | https://conductscience.org/library/papers/39329710 | PubMed |
| 38461171 | Platelets induce CD39 expression in tumor cells to facilitate tumor metastasis. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38461171 | PubMed |
| 38263981 | Unlocking antitumor immunity with adenosine receptor blockers. | Cancer Drug Resist | 2023 | https://conductscience.org/library/papers/38263981 | PubMed |
| 37894719 | NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894719 | PubMed |
| 36829496 | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/36829496 | PubMed |
| 36671461 | Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes. | Biomolecules | 2022 | https://conductscience.org/library/papers/36671461 | PubMed |
| 35775486 | Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35775486 | PubMed |
| 35738682 | ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain. | Pharmacol Rev | 2022 | https://conductscience.org/library/papers/35738682 | PubMed |
| 35386701 | Adenosine-A2A Receptor Pathway in Cancer Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35386701 | PubMed |
| 34442398 | Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442398 | PubMed |
| 34145990 | Metabolic regulation in the immune response to cancer. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/34145990 | PubMed |
| 32728220 | Targeting CD39 in cancer. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/32728220 | PubMed |
| 32351498 | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. | Front Immunol | 2020 | https://conductscience.org/library/papers/32351498 | PubMed |
| 32098829 | On the mechanism of anti-CD39 immune checkpoint therapy. | J Immunother Cancer | 2020 | https://conductscience.org/library/papers/32098829 | PubMed |
| 31699796 | Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity. | Cancer Discov | 2019 | https://conductscience.org/library/papers/31699796 | PubMed |
| 31244820 | Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. | Front Immunol | 2019 | https://conductscience.org/library/papers/31244820 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ITGAV | 3685 | PubTator's text mining | https://conductscience.org/library/genes/3685 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17823293
GET https://conductscience.org/api/papers/v1/17823293/references?page=2